A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital. . . . → Read More: 3-D Organ Printing Company Gains Seed Funds
|
|||||
|
|
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion  One comment - (Comments are closed)  Finance  biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, licensing, life sciences, merger, NIH, pharmaceuticals A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students. . . . → Read More: University Spins Off Educational Robot Start-Up Comments are closed Finance, New products computer science, crowdfunding, engineering, entrepreneurs, equity, investment, licensing, mathematics, physical sciences, robotics, software, university, venture capital A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital On Wednesday, Standard & Poor’s index of 500 stocks in the information technology industry closed at 992.29, its highest point since March 2000, at the height of the dot-com boom, when the index reached 988.49. . . . → Read More: S&P 500 Tech Stocks Surpass Dot-Com Peak A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs. . . . → Read More: Start-Up Applying Artificial Intelligence to New Drug Uses One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, computer science, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, software, venture capital A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing. . . . → Read More: Immune Disease Start-Up Raises $28M in Early Funds Comments are closed Finance biomedical, entrepreneurs, equity, Europe, investment, licensing, life sciences, pharmaceuticals, venture capital A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes Comments are closed Joint ventures/collaborations biomedical, biotechnology, engineering, equity, genomics, investment, life sciences, venture capital |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
